Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurodegenerative diseases
Biotech
Voyager pauses Alzheimer's program 8 months after unveiling med
Voyager Therapeutics has hit pause on a preclinical Alzheimer’s disease program just eight months after unveiling the asset.
James Waldron
Mar 10, 2026 10:20am
Cognito reaps $105M in funding for its Alzheimer's device
Mar 6, 2026 7:30am
Ionis scraps Alzheimer's candidate for people with Down syndrome
Feb 20, 2026 1:50pm
GSK inks 5-year deal with Jackson Lab for neuro research
Feb 18, 2026 3:30pm
Korsana crosses into crowded Alzheimer's field with $175M
Feb 18, 2026 6:00am
Lilly drops 3 clinical programs, including Prevail gene therapy
Feb 4, 2026 12:33pm
